Biotech, Pharma Stocks Surge as IPAB Not Triggered
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 near flat as traders shift out of risky AI bets
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Pharma Rumor Mill Working Overtime
June 22, 2016 3:53 PM EDTIn addition to the positive implications from the IPAB not being triggered, there is a lot of under-the-radar chatter going around today about a possible mega-deal in the biotech/pharma space.
Two specific deals were mentioned in the rumor mill today:
Pfizer (NYSE:... More


